Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




A Phase II Randomized Crossover Study of Liposomal Doxorubicin Versus Weekly Docetaxel in the First-
Link ID 21488
Title A Phase II Randomized Crossover Study of Liposomal Doxorubicin Versus Weekly Docetaxel in the First-
Url http://www.medscape.com/viewarticle/714171?src=rss
Description Metastatic breast cancer first-line treatments with varying dosing frequencies are compared for efficacy and toxicity. Is one regimen superior? Clinical Breast Cancer
Category Articles > Hematology-Oncology
Keywords
Date Jan 6, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Cancer SurvivorshipCancer Survivorship
  Children who have survived cancer are the largest group of survivors. Yet, they are the most vulnerable of this population. Dr. Maris discusses their unique healthcare needs. CHOP Expert Commentary
Category:   Articles > Hematology-Oncology


2. SNM 2009: FDG-PET/CT May Be Superior to CA-125 in Detecting Ovarian Cancer Recurrence
  FDG-PET/CT can provide a more precise assessment of recurrence and outcome in ovarian cancer than the standard serum tumor marker. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. Combination of Implants Benefits Patients With Recurrent Glioblastoma
  The combination of permanent iodine-125 seed implants and carmustine (BCNU) wafers is safe and effective in patients with recurrent glioblastoma multiforme (GBM), according to a report in the February issue of the Journal of Neurosurgery. Reuters Health Information
Category:   Articles > Hematology-Oncology


4. ASH 2008: Addition of Rituximab Benefits Chronic Lymphocytic Leukemia
  Two of the largest trials ever conducted in chronic lymphocytic leukemia show that the addition of rituximab to chemotherapy significantly improves progression-free survival. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. A Multicentre Phase II Gene Expression Profiling Study of Putative Relationships Between Tumour Biom
  Selection for advanced NSCLC treatment with erlotinib may be guided by identification of tumor biomarkers that predict clinical benefit. Annals of Oncology
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS